Oncotype Dx use and its relationship with chemotherapy administration in the general population

被引：0
作者：
Chavez-MacGregor, Mariana [1 ]
Niu, Jiangong [1 ]
Smith, Benjamin [1 ]
Zhao, Hui [1 ]
Buchholz, Thomas A. [1 ]
Giordano, Sharon H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-07-05
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Prediction of Oncotype DX Recurrence Score: Use of a Pathology Generated Equation
    Hou, Yanjun
    Tozbikian, Gary
    Zynger, Debra L.
    Li, Zaibo
    [J]. MODERN PATHOLOGY, 2016, 29 : 45A - 45A
  • [42] Use of Oncotype DX DCIS for disease management in a prospective DCIS registry
    Wei, Jane M.
    Kim, Paul
    Ewing, Cheryl
    Wong, Jasmine
    Esserman, Laura J.
    Alvarado, Michael D.
    Olusanya, Abimbola O.
    Stewart, Skye
    Tydon, Ashley
    Daroui, Parima
    Kuo, Jeffrey V.
    Park, Hannah L.
    Lane, Karen T.
    Jeong, Eliza
    Brown, Kelsey
    Hosseini, Ava
    Parker, Barbara A.
    Blair, Sarah L.
    Baehner, Frederick
    Harismendy, Olivier
    Petruse, Antonia
    Thompson, Carlie K.
    Chang, Helena R.
    Borowsky, Alexander D.
    Yau, Christina
    Hirst, Gillian L.
    Bold, Richard J.
    Mukhtar, Rita A.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [43] Appropriate use of Oncotype DX in breast cancer patients: An NCDB analysis
    Govert, Kristen
    Voci, Amy
    Walsh, Kendall
    Boselli, Danielle
    Hadzikadic-Gusic, Lejla
    Forster, Meghan
    Sarma, Deba
    Sarantou, Terry
    White, Richard, Jr.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 177 - 178
  • [44] RETROSPECTIVE BUDGET IMPACT ANALYSIS ON THE USE OF THE ONCOTYPE DX® TEST IN IRELAND
    Falahee, M.
    Plun-Favreau, J.
    Ercoli, K.
    [J]. BREAST, 2013, 22 : S112 - S112
  • [45] Relationship of histologic grade and histologic subtype with oncotype Dx recurrence scoreI3/4 retrospective review of 863 breast cancer oncotype Dx results
    Singh, Kamaljeet
    He, Xin
    Kalife, Elizabeth T.
    Ehdaivand, Shahrzad
    Wang, Yihong
    Sung, C. James
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 29 - 34
  • [46] Application of Microsatellite Instability and Oncotype DX in Stage II Colon Cancer Adjuvant Chemotherapy
    Chu, Edward
    [J]. CURRENT COLORECTAL CANCER REPORTS, 2011, 7 (04) : 260 - 266
  • [47] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
    Lindsay J. Collin
    Ming Yan
    Renjian Jiang
    Kevin C. Ward
    Brittany Crawford
    Mylin A. Torres
    Keerthi Gogineni
    Preeti D. Subhedar
    Samantha Puvanesarajah
    Mia M. Gaudet
    Lauren E. McCullough
    [J]. npj Breast Cancer, 5
  • [48] Oncotype DX Testing for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer Management
    Rabie, M.
    Rankin, A.
    Youssef, M.
    Burger, A.
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 : 145 - 145
  • [49] Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria
    Zekri, Jamal
    Al-Foheidi, Meteb
    Alata, Maaz
    Zabani, Reem
    Rasmy, Ayman
    [J]. BREAST CARE, 2020, 15 (06) : 642 - 647
  • [50] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
    Collin, Lindsay J.
    Yan, Ming
    Jiang, Renjian
    Ward, Kevin C.
    Crawford, Brittany
    Torres, Mylin A.
    Gogineni, Keerthi
    Subhedar, Preeti D.
    Puvanesarajah, Samantha
    Gaudet, Mia M.
    McCullough, Lauren E.
    [J]. NPJ BREAST CANCER, 2019, 5 (1)
12345